Pharma CDMOs in India

Pharma CDMOs in India & CDMO 2.0 Model:...

Samrat Pradhan, Managing Editor at India Pharma Outlook

Explore the evolution of Pharma CDMOs in India and the rise of the CDMO 2.0 model in 2026. Discover key trends, market growth, biologics, digital...

Computer aided drug design (CADD), drug discovery, 3D bioprinting technology, AI based supercomputing, Internet of Things (IoT)

Advancements in Computer-Aided Drug Design for...

Computer aided drug design (CADD) has played a pivotal role in...

Shishir Agarwal, President & Managing Director, Terumo India

The Future of MedTech in India: Meeting Tier-2 and Tier-3 Needs

In an exclusive interaction with Thiruamuthan, Assistant Editor at India Pharma Outlook, Shishir Agarwal, President and Managing Director, Terumo India, discusses how MedTech companies are adapting...

Shishir Agarwal, President & Managing Director, Terumo India

Role

Role of Wellness in Corporate & Community Health

C. Mukundan, Managing Partner, Regen Labs

Wellness initiatives enhance employee performance by improving health focus and engagement while fostering long-term community health through...

Sandeep Raktate, President - India & Ireland Operations, Amneal Pharmaceuticals

How Digital Maturity is Powering Pharma's GMP Evolution

Sandeep Raktate, President - India & Ireland Operations, Amneal Pharmaceuticals

In an exclusive interview with Thiruamuthan, Assistant Editor at India Pharma Outlook, Sandeep Raktate, President - India & Ireland Operations,...

Saransh Chaudhary, President, Global Critical Care, Venus Remedies Ltd

India's Rare Disease Shift Driven by PRIP and PLI Policies

Saransh Chaudhary, President, Global Critical Care, Venus Remedies Ltd & CEO, Venus Medicine Research Centre

Saransh Chaudhary, President, Global Critical Care, Venus Remedies Ltd & CEO, Venus Medicine Research Centre, engaged in a conversation with...

Most Viewed

Pharma CDMOs in India

Pharma CDMOs in India & CDMO 2.0 Model:...

Samrat Pradhan, Managing Editor at India Pharma Outlook

Explore the evolution of Pharma CDMOs in India and the rise of the CDMO 2.0 model in 2026. Discover key trends, market growth, biologics, digital...

Pharma Financial Year-EndIndia Pharma Outlook

Pharma Financial Year-End Checklist 2026: Key Stats & Compliance

Zeenat Parween, Correspondent, India Pharma Outlook

Year-end is where most pharma companies slip. Not because of big mistakes—but small misses...

Semaglutide, GLP-1 Receptor Agonist, India Pharma Outlook

How Semaglutide Works: The Breakthrough Weight-Loss Drug

Zeenat Parween, Correspondent, India Pharma Outlook

Walk into any urban clinic in India today and you will hear one name migrating from...

 Biopharma SHAKTI Scheme

How to Apply for India's Rs 10,000 Crore Biopharma SHAKTI Scheme

Thiruamuthan, Assistant Editor, India Pharma Outlook

India's pharma sector evolves with Biopharma SHAKTI Scheme, focusing on biologics,...

Computer aided drug design (CADD), drug discovery, 3D bioprinting technology, AI based supercomputing, Internet of Things (IoT)

Advancements in Computer-Aided Drug Design for...

Computer aided drug design (CADD) has played a pivotal role in...

kidney transplant

The Future of Kidney Transplants in India

A milestone has been achieved by Fortis Hospital, Bengaluru...

clinical trials, clinical research, bio-pharma sector, Drugs and Cosmetics Act of 1940, Startups in the bio-pharma sector, artificial intelligence (AI

Why India is Gaining Popularity for Clinical Trials

India has successfully performed the first human clinical...

conversational AI, Health insurance, consumer literacy, consumer education, health insurance providers

Usage of Conversational AI in the Health Insurance Sector

At the Conversational AI and Customer Experience summit last...